Initial Phase II Results with Crizotinib in Advanced ALK-Positive Non-Small-Cell Lung Cancer (NSCLC): PROFILE 1005
Invited conference paper presented and published in conference proceedings

香港中文大學研究人員

全文

其它資訊
著者MOK Shu Kam Tony, CRINO L, KIM D, RIELY Gj, JANNE Pa, BLACKHALL Fh, CAMIDGE Dr, HIRSH V, SOLOMON Bj, PARK K, GADGEEL Sm, MARTINS R, HAN J, DE PAS Tm, BOTTOMLEY A, POLLI A, PETERSEN J, TASSELL Vr, SHAW At
會議名稱2011 ASCO Annual Meeting Proceedings
會議國家/地區美國
會議論文集題名2011 ASCO Annual Meeting Proceedings
詳細描述organized by American Society of Clinical Oncology,
出版年份2011
月份6
出版地United States of America
頁次479
語言英式英語
關鍵詞Crizotinib; ALK-positive; NSCLC

上次更新時間 2018-20-01 於 02:15